| Structure | Chemical Name | CAS | MF |
|
4-Methylsulfonyl-2,2',3,4',5',6-hexachlorobiphenyl
|
116806-76-9
|
C13H6Cl6O2S
|
|
3-Methylsulfonyl-2,3',4',5,6-pentachlorobiphenyl
|
116807-23-9
|
C13H7Cl5O2S
|
|
3-Methylsulfonyl-2,2',4',5-tetrachlorobiphenyl
|
116807-52-4
|
C13H8Cl4O2S
|
|
3-Methylsulfonyl-2,3',4',5-tetrachlorobiphenyl
|
116807-53-5
|
C13H8Cl4O2S
|
|
(4-METHOXYPHENYL)DIPHENYLSULFONIUM TRIFLATE
|
116808-67-4
|
C20H17F3O4S2
|
|
1-NAPHTHYL DIPHENYLSULFONIUM TRIFLATE
|
116808-69-6
|
C23H17F3O3S2
|
|
Alcohols, C18-22, ethoxylated
|
116810-32-3
|
|
|
|
Tetrakis(trimethyl(C=12-18)tallow ammonium)hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-)
|
116810-46-9
|
|
|
|
Siloxanes and Silicones, di-Me, 3-hydroxypropyl group-terminated, diesters with 2-oxepanone homopolymer acetate
|
116810-47-0
|
|
|
|
Siloxanes and Silicones, di-Me, polymers with ethylene glycol, methoxy-terminated Ph silsesquioxanes, terephthalic acid and trimethylolpropane
|
116810-48-1
|
|
|
|
cecropin AD
|
116811-00-8
|
|
|
8-CHLORO-1,2,3,4-TETRAHYDRO-BENZO[B]AZEPIN-5-ONE
|
116815-03-3
|
C10H10ClNO
|
|
3-Buten-2-one, 4-(1-methylcyclopropyl)-, (E)- (9CI)
|
116815-79-3
|
C8H12O
|
|
3-Buten-2-one, 4-(1-methylcyclobutyl)-, (E)- (9CI)
|
116815-81-7
|
C9H14O
|
|
3-Butyn-2-one,4-cyclopentyl-
|
116815-83-9
|
C9H12O
|
|
Cyclopentanecarboxylic acid, 1-fluoro-, ethyl ester (9CI)
|
116816-10-5
|
C8H13FO2
|
|
(RS)-N-Methyl-gama-(1-naphthalenyloxy)-2-thiophenepropanamine hydrochloride
|
116817-11-9
|
C19H21NOS
|
|
S-(+)-N,N-DIMETHYL-3-(1-NAPHTHLENYLOXY)-3-(2-THIENYL)-PROPANAMINE
|
116817-12-0
|
C21H23NO5S
|
|
(±)-Duloxetine
|
116817-13-1
|
C18H19NOS
|
|
(±)-Duloxetine-d5 Oxalate (N-methyl-dj propanamine-d2)
|
116817-14-2
|
C20H21NO5S
|
|
3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1)
|
116817-26-6
|
C21H23NO5S
|
|
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine
|
116817-27-7
|
C18H19NOS
|
|
rac Duloxetine 3-Thiophene IsoMer Oxalate
|
116817-28-8
|
C20H21NO5S
|
|
S-(+)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propylamide
|
116817-84-6
|
C9H15NOS
|
|
DULOXETINE MALEATE
|
116817-86-8
|
C18H19NOS.C4H4O4
|
|
Piperazine, 1-(1-aziridinylcarbonyl)-4-methyl- (9CI)
|
116818-62-3
|
C8H15N3O
|
|
1-Piperazinecarboxamide,N-(2-hydroxyethyl)-4-methyl-(9CI)
|
116818-76-9
|
C8H17N3O2
|
|
(4-METHYL-PIPERAZIN-1-YL)-PYRROLIDIN-2-YL-METHANONE
|
116818-82-7
|
C10H19N3O
|
|
Isalsteine
|
116818-99-6
|
C14H15NO6S
|
|
Acetic acid, hydrazide, conjugate monoacid (9CI)
|
116819-13-7
|
C2H7N2O+
|
|
Hydrazinecarboxylic acid, ethyl ester, conjugate monoacid (9CI)
|
116819-16-0
|
C3H9N2O2+
|
|
Mtx-ala
|
116819-28-4
|
C23H27N9O6
|
|
11-AMINOUNDECYLTRIETHOXYSILANE
|
116821-45-5
|
C17H39NO3Si
|
|
FMOC-GAMMA-ABU-OH
|
116821-47-7
|
C19H19NO4
|
|
N-[2-(Diethylamino)ethyl]-1H-benzotriazole-5-carboxamide
|
116822-18-5
|
C13H19N5O
|
|
dimethyl[2-(1H-1,2,3,4-tetrazol-5-yl)ethyl]amine
|
116822-26-5
|
C5H11N5
|
|
Cyclobutanecarboxylic acid, 1-amino-3-(hydroxymethyl)-, trans- (9CI)
|
116823-32-6
|
C6H11NO3
|
|
3-Oxabicyclo[3.1.1]heptan-2-one,1-isocyanato-(9CI)
|
116823-33-7
|
C7H7NO3
|
|
CALMODULIN-DEPENDENT PROTEIN KINASE II (281-309)
|
116826-37-0
|
C146H254N46O39S3
|
|
2-(Trifluoromethoxy)benzylsulphonyl chloride
|
116827-38-4
|
C8H6ClF3O3S
|
|
2-(TrifluoroMethoxy)benzyl chloride
|
116827-40-8
|
C8H6ClF3O
|
|
3'-Fluoro-4''-propyl-[1,1':4',1''-terphenyl]-4-carbonitrile
|
116831-09-5
|
C22H18FN
|
|
[1,1'-Biphenyl]-4-ol, 4'-bromo-2'-fluoro-
|
116831-27-7
|
C12H8BrFO
|
|
4-BROMO-2-FLUORO-4'-PROPYLBIPHENYL
|
116831-33-5
|
C15H14BrF
|
|
4-BROMO-4'-BUTYL-2-FLUOROBIPHENYL
|
116831-34-6
|
C16H16BrF
|
|
3,5-Dibromo-4-aminotrifluoromethoxybenzene
|
116833-10-4
|
C5H5FN4O3S
|
|
2-(ETHYLMETHYLAMINO)ACETAMIDE
|
116833-20-6
|
C5H12N2O
|
|
Propanamide, 2-(dimethylamino)-3-hydroxy-, (R)- (9CI)
|
116833-21-7
|
C5H12N2O2
|
|
1-Piperazinesulfonicacid,4-methyl-(9CI)
|
116833-23-9
|
C5H12N2O3S
|
|
Piperazine, 1-(iminomethyl)-4-methyl- (9CI)
|
116833-32-0
|
C6H13N3
|
|
N,N-dimethyl-1-(1H-tetrazol-5-yl)methanamine(SALTDATA: FREE)
|
116833-33-1
|
C4H9N5
|
|
1-PHENYL-5-(1H-PYRROL-1-YL)-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
116834-08-3
|
C14H11N3O2
|
|
1-(4-Methoxyphenyl)-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxylic acid
|
116834-10-7
|
C15H13N3O3
|
|
4-[(8-QUINOLINYLSULFONYL)AMINO]BENZOIC ACID
|
116834-64-1
|
C16H12N2O4S
|
|
1H-Pyrazolo[3,4-b]pyridine,3-methyl-(9CI)
|
116834-96-9
|
C7H7N3
|
|
1H-Pyrazolo[3,4-b]pyridine,1,3-dimethyl-(9CI)
|
116834-97-0
|
C8H9N3
|
|
1H-Pyrrole,2-methyl-5-(1-methylethyl)-(9CI)
|
116836-25-0
|
C8H13N
|
|
4(3H)-Quinazolinone, 2-amino-8-methyl-
|
116836-27-2
|
C9H9N3O
|
|
8-BroMoquinolin-5-ol
|
116836-28-3
|
C9H6BrNO
|
|
(14R)-14-Hydroxy Clarithromycin
|
116836-41-0
|
C38H69NO14
|
|
(2S)-2-(1H-PYRROL-1-YL)PROPANOIC ACID
|
116838-52-9
|
C7H9NO2
|
|
1,2-O-Cyclohexylidene-4-O-(phenylMethyl)-D-Myo-inositol
|
116839-47-5
|
C19H26O6
|
|
Posiphen
|
116839-68-0
|
C20H23N3O2
|
|
5-[(1E)-3-Amino-1-propen-1-yl]-2'-deoxyuridine 5'-(tetrahydrogen triphosphate)
|
116840-18-7
|
C12H20N3O14P3
|
|
2,3,4,7,8-PENTACHLORODIBENZOFURAN (13C12, 99%) 50 ug/ml in Nonane
|
116843-02-8
|
C12H3Cl5O
|
|
1,2,3,6,7,8-HEXACHLORODIBENZOFURAN (13C12, 99%) 50 ug/ml in Nonane
|
116843-03-9
|
C12H2Cl6O
|
|
1,2,3,7,8,9-HEXACHLORODIBENZOFURAN (13C12, 99%) 50 ug/ml in Nonane
|
116843-04-0
|
C12H2Cl6O
|
|
2,3,4,6,7,8-HEXACHLORODIBENZOFURAN (13C12, 99%) 50 ug/ml in Nonane
|
116843-05-1
|
C12H2Cl6O
|
|
fluorescein isothiocyanate-phenylglyoxal
|
116843-39-1
|
C29H18N2O7S
|
|
BUCCALIN
|
116844-51-0
|
C45H72N12O15S
|
|
|
Basic Yellow 87
|
116844-55-4
|
|
|
|
Solvent orang
|
116844-59-8
|
|
|
Pregna-1,4,9(11)-triene-3,20-dione, 21-chloro-17-hydroxy-16-methyl-, (16β)-
|
116846-77-6
|
C22H27ClO3
|
|
Duralloy
|
116848-45-4
|
Ag5Cu2Sn3
|
|
1H,3H-Thiazolo[3,4-a]benzimidazole,1-methyl-(9CI)
|
116849-82-2
|
C10H10N2S
|
|
2-CHLORO-3-FLUOROTOLUENE
|
116850-28-3
|
C7H6ClF
|
|
4-methyl-3-methylsulfonyl-5-phenyl-1,2,4-triazole
|
116850-44-3
|
C10H11N3O2S
|
|
2-(2-fluorobenzoyl)-N-methyl-1-hydrazinecarbothioamide
|
116850-73-8
|
C9H10FN3OS
|
|
2,2-Aziridinedicarboxylicacid,monomethylester(9CI)
|
116850-90-9
|
C5H7NO4
|
|
Cefluprenam
|
116853-25-9
|
C20H25FN8O6S2
|
|
Propanamide, 2-(dimethylamino)-3-hydroxy-, (S)- (9CI)
|
116853-49-7
|
C5H12N2O2
|
|
4-Pyridinecarbonylfluoride,2-fluoro-(9CI)
|
116853-95-3
|
C6H3F2NO
|
|
2-Chloro-6-methoxyisonicotinoyl chloride
|
116853-97-5
|
C7H5Cl2NO2
|
|
1H-INDENE-1-CARBOXYLIC ACID, 2,3-DIHYDRO-5-METHOXY-
|
116854-10-5
|
C11H12O3
|
|
3-NITRO-1H-PYRAZOLO[3,4-B]PYRIDINE
|
116855-00-6
|
C6H4N4O2
|
|
3-Bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine
|
116855-03-9
|
C7H6BrN3
|
|
1H-Pyrazolo[3,4-b]pyridine-3-carboxylicacid(9CI)
|
116855-08-4
|
C7H5N3O2
|
|
1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBOXYLIC ACID
|
116855-09-5
|
C8H7N3O2
|
|
1H-Pyrazolo[3,4-b]pyridine-6-carboxamide(9CI)
|
116855-16-4
|
C7H6N4O
|
|
4-[(ETHYLSULFONYL)AMINO]BENZOIC ACID
|
116855-56-2
|
C9H11NO4S
|
|
(cyclohexylmethyl)(prop-2-en-1-yl)amine
|
116855-58-4
|
C10H19N
|
|
Formamide, N-(2,3-dihydro-2-thioxo-6-benzothiazolyl)- (9CI)
|
116855-73-3
|
C8H6N2OS2
|
|
(3aS,4R,5R,6aR)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-N-[(1R)-2-hydroxy-1-phenylethyl]-5,5-dimethyl-spiro[1,3-dioxane-2,2(1H)-pentalene]-4-carboxamide
|
116855-81-3
|
C28H45NO5Si
|
|
5-Formamide-1-(2-formyloxyethl)pyrazole
|
116856-18-9
|
C7H9N3O3
|
|
3-Cyclopentene-1-carboxamide,N-ethyl-(9CI)
|
116856-35-0
|
C8H13NO
|
|
3-Cyclopentene-1-carboxamide,N-ethyl-2-hydroxy-,trans-(9CI)
|
116856-36-1
|
C8H13NO2
|
|
6-Oxabicyclo[3.1.0]hexane-3-carboxamide,N-ethyl-,(1alpha,3alpha,5alpha)-(9CI)
|
116856-40-7
|
C8H13NO2
|
|
2,2-Dimethyltetrahydro-4,7-Methano[1,3]Dioxolo[4,5-C]Pyridin-6(3aH)-One(WXC03101)
|
116856-49-6
|
C9H13NO3
|
|
TERT-BUTYL 3-[4-(2-AMINO-ETHYL)-PHENYL]-PROPIONATE HYDROCHLORIDE
|
116856-71-4
|
C15H24ClNO2
|
|
trans-4,5-Dichloro-4,5-diMethyl-1,3-dioxolan-2-one
|
116857-05-7
|
C5H6Cl2O3
|